SynthesisFrontiers in medicine2025
Factors influencing stigma in Chinese postoperative breast cancer patients: a systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The development trajectory of self-advocacy in patients with adjuvant chemotherapy after breast cancer surgery and its predictors.Medicine · 2026Article
- Preparedness for generative AI adoption among Chinese cancer survivors: a multi-center cross-sectional survey study.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To systematically evaluate stigma levels and its influencing factors among Chinese postoperative breast cancer patients, providing evidence for culturally adapted interventions. Methods: Chinese and English databases, such as China Biology Medicine Disc (CBM), China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform (WangFang), China Science and Technology Journal Database (The VIP), Cochrane Library, PubMed, Embase, Scopus, Medline, Web of Science, and grey literature from the National Institute for Health Research (NIHR), were searched. The time limit of the search for literature on the factors affecting the level of stigma in Chinese postoperative breast cancer patients was from the establishment of the databases to 14 July 2025. Two researchers independently screened studies, extracted data, and assessed quality using AHRQ criteria. Meta-analyses were performed using Stata 18.0. Results: Fourteen cross-sectional studies (total Conclusion: Chinese breast cancer survivors face severe stigma shaped by Confucian familial norms, economic pressures, and healthcare disparities. Interventions must prioritize marital counseling, occupational reintegration, accessible reconstruction, and rural mental health services. Longitudinal studies are needed to establish causality. Systematic review registration: CRD42024502898, https://www.crd.york.ac.uk/PROSPERO/recorddashboard.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.